← Back to Clinical Trials
Recruiting NCT04255693

Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence

Trial Parameters

Condition Gastroesophageal Reflux Disease
Sponsor Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology
Study Type INTERVENTIONAL
Phase N/A
Enrollment 150
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2020-01-31
Completion 2027-12-31
Interventions
diet adherenceNo diet adherenceChange in physical activity

Brief Summary

This study is aimed to investigate the role of long-term diet adherence on manifestations of gastroesophageal reflux disease

Eligibility Criteria

Inclusion Criteria: * willingness to participate (based on the signed informed consent form); * presence of gastroesophageal reflux disease, based on the following: a) typical symptoms, like heartburn and/or regurgitation (for primary selection, symptoms should be present at least weekly, be actual for at least 3 months prior to the enrolment, and the patient should report the history of symptoms which lasts for at least 6 months); b) previous response to the intake of proton pump inhibitors; c) data of 24-hours oesophageal pH-impedance monitoring with detected pathological gastroesophageal reflux according to the Lyon consensus definitions; Exclusion Criteria: * pregnant or breast-feeding females; * abdominal or chest surgery (except appendectomy or cholecystectomy in case they are not followed by adhesive disease of the abdominal organs); * constant use of non-steroidal anti-inflammatory agents (NSAIDs), sporadic use of NSAIDs will be allowed in case the course of treatment was disco

Related Trials